Register
Login:
Share:
Email Facebook Twitter


UPDATE: #COPL set timeline for Q2/Q3 Nigeria drilling programme
RESULTS: IFA led wealth managers AFH Financial results show strong growth




Share Price Information for Synairgen (SNG)


Share Price: 17.10Bid: 16.70Ask: 17.50Change: 0.00 (0.00%)No Movement on Synairgen
Spread: 0.80Spread as %: 4.79%Open: 17.35High: 17.35Low: 16.70Yesterday’s Close: 17.10

Synairgen Plc Ord 1P

Synairgen is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
17.10
Share Price SpacerBid
16.70
Share Price SpacerAsk
17.50
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
17.35
Share Price SpacerHigh
17.35
Share Price SpacerLow
16.70
Share Price SpacerClose
17.10
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 109.32m £18.69m 10,000

52 Week High 26.50 52 Week High Date 4-JUL-2018
52 Week Low 11.75 52 Week Low Date 29-MAR-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 8.860 1.93 0.00 0.00


London South East Users info for Synairgen




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

13-Feb-19
09:12:39
16.70
10,000
Sell* 
16.70
17.50
1,670
Trade Type:
Ordinary

13-Feb-19
08:56:29
17.00
10,500
Sell* 
16.70
17.50
1,785
Trade Type:
Ordinary

12-Feb-19
16:13:13
16.71
4,642
Sell* 
16.70
17.50
775.68
Trade Type:
Ordinary




View more Synairgen trades >>

Directors Deals for Synairgen (SNG)
Trade DateActionNotifierPriceCurrencyAmountHolding
12-Oct-18Buy
Trade Notifier Information for Synairgen
Richard J Marsden held the position of CEO at Synairgen at the time of this trade.
 Richard J Marsden
16GBX156,250310682
12-Oct-18Buy
Trade Notifier Information for Synairgen
John C Ward held the position of Finance Director at Synairgen at the time of this trade.
 John C Ward
16GBX62,500339006
12-Oct-18Buy
Trade Notifier Information for Synairgen
Phillip David Monk held the position of Chief Scientific Officer at Synairgen at the time of this trade.
 Phillip David Monk
16GBX46,875230314
View more Synairgen directors dealings >>


cadburyhill
Posts: 462
Opinion:Strong Buy
Price:17.10
Gilead phase 3 NASH fail
Tue 13:00
I note a failure of a major phase 3 NASH trial at Gilead last night.... At the margin, this increases the interest and value of our fibrosis product, which is in the process of being licensed out by our Australian friends...NASH/fibrosis is such a massive, largely unmet area of need....
RichTheNewbie
Posts: 19,063
Opinion:No Opinion
Price:16.75
RE: Charts
7 Feb '19
Building on my previous guesstimate I've noticed that this is setting up very much in line with two common bullish chart patterns in case any of you like that sort of thing.

Inverse Head and Shoulders formation: https://pbs.twimg.com/media/Dy0GsqPXQAAvCX2.jpg:large

Cup and Handle formation: https://pbs.twimg.com/media/Dy0Hg26X0AEpVpB.jpg:large
RichTheNewbie
Posts: 19,063
Opinion:No Opinion
Price:17.00
RE: Charts
1 Feb '19
Closing bracket should obviously have been after "here" in the first sentence, not at the end.
Ballsed that up.
RichTheNewbie
Posts: 19,063
Opinion:No Opinion
Price:17.00
RE: Charts
1 Feb '19
As I'm bullish (or I wouldn't be here I see this playing out a couple of ways most likely).
https://www.tradingview.com/x/2n57z3sZ/

Either it bounces off the second upper black line and breaks up and outwards through it.
OR
It dips back through the second upper black line, into the main uptrend channel, and into the shaded cyan circle.

I think the last test of the bottom of the channel showed nobody wants to sell and it bounced strongly upwards and therefore I expect if it dips into the cyan area, with the usual spread of 1p or 1.5p, most of the bottom half of the circle will be the spread itself, and therefore there'll be a very short amount of time to buy at 15.5 or more likely around 16p at best. I expect it then to head back to the top of the channel again and try to break it.

So selling to buy back would be quite risky in terms of being locked out, if it bounces upwards in scenario 1, whether due to news, simply due to buying/lack of selling. It wouldn't also be particularly worth it in scenario 2 as, after taking account of the spread, you probably wouldn't be making very much at all.

Of course neither scenarios might be right......but personally I think it's very likely one of them will be ;)
Y-Alam
Posts: 273
Opinion:Strong Buy
Price:17.00
Charts
1 Feb '19
Indicate some pullback followed by a renewed uptrend. Good time to pick a few more up in coming days.
View more share chat for Synairgen (SNG) >>




Synairgen Plc Ord 1P home pageWebsite: Synairgen Plc Ord 1P
Website Description: New Treatments for Respiratory Diseases - Synairgen Ltd



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.